Nordlinger B, Guiguet M, Vaillant J C, Balladur P, Boudjema K, Bachellier P, Jaeck D
Centre de Chirurgie Digestive, Hôpital Saint Antoine, Paris, France.
Cancer. 1996 Apr 1;77(7):1254-62.
Five-year survival rates after resection of liver metastases from colorectal carcinoma are close to 25%. Recurrences occur in two-thirds of the patients after surgery. Selection of patients likely to benefit from surgery remains controversial and subjective.
Data from 1568 patients with resected liver metastases from colorectal carcinoma were collected. The prognostic value of different factors was studied through uni- and multivariate analyses. A scoring system was developed including the most relevant factors.
Two- and 5-year survival rates were 64% and 28%, respectively, and were affected by: age; size of largest metastasis or CEA level; stage of the primary tumor; disease free interval; number of liver nodules; and resection margin. Giving one point to each factor, the population was divided into three risk groups three risk groups with different 2-year survival rates: 0-2 (79%), 3-4 (60%), 5-7 (43%).
A simple prognostic scoring system was proposed to evaluate the chances for cure of patients after resection of liver metastases from colorectal carcinoma. The comparison between expected survival and estimated operative risk can help determine on an objective basis whether surgery is worthwhile. This system needs further prospective validation.
结直肠癌肝转移灶切除术后的五年生存率接近25%。三分之二的患者术后会复发。选择可能从手术中获益的患者仍然存在争议且主观。
收集了1568例结直肠癌肝转移灶切除患者的数据。通过单因素和多因素分析研究了不同因素的预后价值。开发了一个包含最相关因素的评分系统。
两年和五年生存率分别为64%和28%,并受以下因素影响:年龄;最大转移灶大小或癌胚抗原(CEA)水平;原发肿瘤分期;无病间期;肝结节数量;以及切缘。每个因素计1分,将患者分为三个风险组,三个风险组的两年生存率不同:0 - 2分(79%),3 - 4分(60%),5 - 7分(43%)。
提出了一个简单的预后评分系统,以评估结直肠癌肝转移灶切除术后患者的治愈机会。预期生存与估计手术风险之间的比较有助于客观地确定手术是否值得。该系统需要进一步的前瞻性验证。